U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07109219) titled 'Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia' on July 07.
Brief Summary: The study is intended to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of AZD4512 in patients with relapsed/refractory B-Cell acute lymphoblastic leukemia (r/r B-ALL).
Study Start Date: Oct. 31
Study Type: INTERVENTIONAL
Condition:
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Intervention:
COMBINATION_PRODUCT: AZD4512 monotherapy
Patients will receive AZD4512 as monotherapy via intravenous infusion. AZD4512 is an antibody-drug conjugate targeting ...